During 2024, we incurred approximately $62,300,000 in capital expenditures of which $27,800,000 was for Montauk Ag Renewables, twelve point six million dollars was for the second Apex facility and $8,800,000 was for the Bowerman RNG project. For 2023, our capital expenditures were $63,100,000 of which $18,600,000 was for Montauk Ag Renewables, thirteen point seven million dollars was for the Pico facility digestion capacity increase and $13,100,000 was for the second Apex RNG facility. In 2025, we expect our non development 2025 capital expenditures to range between $14,000,000 and $17,000,000 Additionally, we currently expect that our existing 2025 development capital expenditures will range between $100,000,000 and $150,000,000 As of 12/31/2024, we had cash and cash equivalents of approximately $45,600,000 and accounts and other receivables of approximately $8,200,000 We don't believe we have any collectability issues with our receivables balance. Adjusted EBITDA for 2024 was $42,600,000 a decrease of $3,900,000 or 8.3% compared to $46,500,000 for 2023. EBITDA for 2024 was $41,000,000 a decrease of $4,300,000 or 9.5% compared to EBITDA of $45,300,000 for 2023.